BioNTech SE (ETR:22UA)
Germany · Delayed Price · Currency is EUR 91.35
-4.60 (-4.79%)
At close: Aug 1, 2025, 5:30 PM CET
BioNTech SE Employees
BioNTech SE had 6,772 employees as of December 31, 2024. The number of employees increased by 639 or 10.42% compared to the previous year.
Employees
6,772
Change (1Y)
639
Growth (1Y)
10.42%
Revenue / Employee
$405,538
Profits / Employee
-$113,113
Market Cap
22.89B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6,772 | 639 | 10.42% |
| Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
| Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
| Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
| Dec 31, 2020 | 1,941 | 631 | 48.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Healthineers AG | 72,000 |
| Merck KGaA | 59,020 |
| Bayer Aktiengesellschaft | 91,864 |
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Sartorius Aktiengesellschaft | 13,528 |
| Fielmann Group AG | 24,363 |
| Carl Zeiss Meditec AG | 5,730 |
BioNTech SE News
- 2 days ago - Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent - Fast Company
- 2 days ago - BioNTech Q2 2025 Earnings Preview - Seeking Alpha
- 2 days ago - A Look Ahead: BioNTech's Earnings Forecast - Benzinga
- 2 days ago - Pfizer/BioNTech lose appeal to reverse Moderna’s COVID vaccine patent win in U.K. - Seeking Alpha
- 2 days ago - UK Court of Appeal Confirms Moderna’s EP'949 Patent is Valid and Infringed by Pfizer/BioNTech - Wallstreet:Online
- 2 days ago - Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win - Reuters
- 3 days ago - Pandemic darlings Moderna, BioNTech are now on two different paths - CNBC
- 9 days ago - Pfizer, BioNTech win EU backing for updated COVID shot - Seeking Alpha